Connect with us

Government

Eight Farming Investments to Buy as Putin Ruins Ukrainian Exports

Eight farming investments to buy provide fertile opportunities despite  Russia’s President Vladimir Putin continuing its onslaught against Ukraine and…

Published

on

Eight farming investments to buy provide fertile opportunities despite  Russia’s President Vladimir Putin continuing its onslaught against Ukraine and its people.

The eight farming investments to buy feature stocks and broad commodity funds that offer a chance for investors to benefit from multiple catalysts. One of the key reasons to buy agricultural stocks and funds is that grain and oilseed prices are rising.

Global grain and oilseed markets were tight heading into 2022, and the war in Ukraine has only strengthened their fundamentals, according to a recent report from BofA Global Research. Since the start of the year, Chicago Board of Trade (CBOT) wheat prices nearly doubled from $7.80 per bushel to $14.25 before settling back down to $10.9275 per bushel on May 9.

Meanwhile, corn prices have climbed past $8.11 per bushel, an increase of more than 30% so far this year, while soybean prices have rallied more than 30%, reached $17.40 per bushel late last month and closed at $15.8525 per bushel on May 9. The three commodities repriced significantly higher, reflecting the likelihood of prolonged disruptions to Ukraine’s agriculture exports and concerns about rising input costs, as well as fertilizer shortages. While prices look high from a historical perspective, tight fundamentals leave the door open for increased spot prices, according to BofA.

Eight Farming Investments to Buy Amid Fertilizer Shortages

Ukraine grain and oilseed shipments have reportedly fallen more than 80% from approximately 5-6mn mt per month in 2020-21 to roughly 1mn mt per month recently, BofA wrote in a recent research note. These lost exports, if annualized, equate to about 10 days of world food supply, BofA added.

“Fuel, fertilizer and seed shortages, and Russian military presence could disrupt Ukraine’s spring planting and wheat crop harvest this summer, which could lead to sustained shortfalls,” BofA warned. “Drought in U.S., Canada and China has the potential to further add to the tightness, especially for wheat.”

Buyers have leaned on other places to source grain, but ultimately the world has less food than before the war, BofA cautioned. If supply shortfalls outside Ukraine materialize, more food security measures may be needed, push prices even higher and hit emerging market economies the hardest.

Eight Farming Investments to Buy Incur 300% Fertilizer Price Hike 

Global fertilizer prices rose at least 300% since 2020 due to soaring energy costs, sanctions and hoarding, BofA wrote. The fertilizer price spike added about $1 per bushel and $0.60 per bushel to corn and soybean costs, respectively. Many farmers may pay the increase, while others could cut their usage.

“Estimating the impact of lower fertilizer use on crop yields is a challenge due to limited data and other factors affecting yields, but there is a positive relationship between fertilizer use on agricultural lands and cereal crop yields,” BofA wrote.

Click here for a free two-week trial of Stock Rover.

Eight Farming Investments to Buy Aided by Sanctions on Russia

The shelling of hospitals, schools, residential areas, churches, nuclear power plants, oil refineries and a theater used as a shelter became a precursor to brutal rapes, torture and outright executions of Ukrainian civilians that caused many countries to put sanctions on Russia. The sanctions include scaling back or severing ties with Russia as a producer of grain, oil and natural gas.

Russia’s loss directly from Putin’s invasion are leading to potential gains for Western oil companies that are trying to fill the void for European and other customers seeking to wean themselves away buying commodities from Russia that are helping to fund the war against Ukraine. As an old adage goes, there always is a bull market somewhere. One of the newest is in agriculture.

Fertilizer Stocks Are Among Eight Farming Investments to Buy

Fertilizer manufacturers appear most likely to profit from Russia’s attack against Ukraine, said Bryan Perry, head of the Cash Machine investment newsletter, as well as the Premium Income, Quick Income Trader, Hi-Tech Trader and Breakout Options Alert advisory services. While there may be “demand destruction” in energy markets, there won’t be in the global food supply and demand curves, he added. 

Bryan Perry heads the Cash Machine newsletter.

Wheat, corn and soybean prices jumped upon the full revelation of the Russian attack of Ukraine, Perry continued. One of the big winners from pure demand and sanctions will be CF Industries Holdings, Inc. (NYSE: CF), a manufacturer and distributor of agricultural fertilizers that include ammonia. The company, based in Deerfield, Illinois, a suburb of Chicago, is facing increased distribution costs, particularly for transportation.

Plus, the cost of producing nitrogen fertilizers is highly dependent on the cost of natural gas, which is the principal raw material and primary fuel source used in ammonia production at the company’s manufacturing facilities. For many producers globally, more than 70% of the total cost to produce ammonia is from the cost of natural gas.

The cost of natural gas varies significantly between geographic locations. For example, European customers may see their burden grow, since natural gas prices have been surging there.

Chart courtesy of www.stockcharts.com

Eight Farming Investments to Buy Include Nutrien

Nutrien Ltd. (NYSE: NTR), a Canadian fertilizer company based in Saskatoon, Saskatchewan, is the largest producer of potash and the third-largest producer of nitrogen fertilizer in the world. The company’s interim chief executive Ken Seitz said Nutrien will boost potash production if supply problems worsen in Russia and Belarus, the world’s second- and third-largest potash-producing countries after Canada.

The economic sanctions imposed by the United States, the European Union and others against Russia may hurt the country’s exports of natural gas, potash and nitrogen. Belarus, a puppet state of Russia, has joined the invasion of Ukraine and must adjust to economic sanctions that have restricted its potash exports.

The decision by Putin to wage war against Ukraine further has raised concerns about wheat, corn and vegetable oil supply problems in the Black Sea region. The result is sharply rising world prices for these agricultural products.

Chart courtesy of www.stockcharts.com

CVR Partners Joins Eight Farming Investments to Buy

CVR Partners LP (NYSE: UAN), of Sugar Land, Texas, makes and provides nitrogen fertilizer products as a subsidiary of Coffeyville Resources, a unit of CVR Energy Inc. UAN is another of Perry’s four farming picks. He told me he likes its 9.2% dividend yield for income seekers.

The company’s nitrogen fertilizer manufacturing facility includes a 1,300-ton-per-day ammonia unit, a 3,000 ton-per-day urea ammonium nitrate (UAN) unit and a dual-train gasifier complex that can produce 89 million standard cubic feet of hydrogen per day. The UAN solution, produced by combining urea, nitric acid and ammonia, is a liquid fertilizer product with a nitrogen content ranging from 28% to 32%.

UAN can be applied more uniformly than non-liquid forms of fertilizer. The solution also can be mixed with herbicides, pesticides and other nutrients to let farmers cut costs by applying several materials simultaneously rather than making separate applications.

Chart courtesy of www.stockcharts.com

Mosaic Ranks Among Eight Farming Investments to Buy

The fourth farming investment favored by Perry is Mosaic Company (NYSE: MOS), a Fortune 500 company headquartered in Tampa, Florida, mines phosphate and potash and urea. The largest U.S. producer of potash and phosphate fertilizer, Mosaic operates through segments such as international distribution and Mosaic Fertilizantes. 

Russia is a major producer of potash, a key crop nutrient used in farming production. Mosaic reported solid earnings on Feb. 22 that were in line with expectations. 

Mosaic’s year-over-year earnings per share (EPS) growth rose about 242%. In addition, pricing pressure in the industry caused by less supply out of Russia has lifted the share price of MOS.

Chart courtesy of www.stockcharts.com

Pension Head Picks MOO as One of the Eight Farming Investments to Buy

Investors should weight the purchase of the ETF VanEck Agribusiness (MOO), said Bob Carlson, a pension fund chairman who also leads the Retirement Watch investment newsletter. The fund, which I personally have owned for years, seeks to track the MVIS Global Agribusiness Index. The index is composed of companies that generate at least 50% of their revenues from agrichemicals, animal health and fertilizers, seeds and traits, farm/irrigation equipment, farm machinery, aquaculture, fishing, livestock and more.

Bob Carlson, who leads Retirement Watch, meets with Paul Dykewicz.

MOO’s largest holdings recently included Deere & Co. (NYSE: DE), Nutrien (NYSE: NTR), Bayer (OTCMKTS: BAYRY), Zoetis (NYSE: ZTS) and Archer-Daniels Midland (NYSE: ADM). The ETF owns more than 50 stocks and has nearly 60% of its holdings in the 10 largest positions.

Chart courtesy of www.stockcharts.com

Carlson Chooses DBA to Join the Eight Farming Investments to Buy

Despite the evils of war, investors have a chance to profit from the rise in agriculture prices and other commodities through the futures markets, even as many other equities pullback. Instead of buying futures directly, investors can buy diversified agriculture commodities through Invesco DB Agriculture (DBA), another ETF, Carlson said.

The fund seeks to track changes in the DBIQ Diversified Agriculture Index Excess Return. The ETF also earns interest income from cash it invests primarily in Treasury securities, while holding them as collateral for the futures contracts.

The major holdings in the index are soybeans, wheat, corn, coffee and live cattle. The index is reconstituted each November.

Chart courtesy of www.stockcharts.com

Money Manager Picks One of Eight Farming Investments to Buy

A seasoned investment professional who likes farming machinery company Deere (NYSE: DE) is Michelle Connell, a former portfolio manager who now serves as president of Dallas-based Portia Capital Management

Michelle Connell, CEO, Portia Capital Management

The rationale for recommending DE, Connell said, includes:

-More than half its revenues come from large agriculture.

-If the War in Ukraine continues, U.S. farmers will benefit from higher prices for their crops.

-Higher farm profits mean that that farmers and farming corporations will be more likely to buy large expensive farm equipment.  

Deere has fallen back more than 15% from its recent high on April 20, so investors might find now to be a good entry point, Connell continued.

Chart courtesy of www.stockcharts.com

KROP Becomes the Final of Eight Farming Investments to Buy

Global X AgTech & Food Innovation ETF (NASDAQ: KROP) looks interesting as a possible buy, Connell continued. KROP is an agricultural technology ETF.

KROP holds companies that are focused on more ecological means of feeding the world, Connell commented. The fund has done well this year, but several of its individual holdings have retreated with the market sell-off, she added.

However, it might be a less risky way to invest in these innovative companies, Connell mentioned.`

A few key holdings of KROP include:

  • Nutrien, the world’s largest fertilizer producer; and
  • Corteva, a spin-off from Dupont that focuses on the development of seeds that are more pest and weather-resistant, as well as uses more environmentally friendly crop chemicals.

Chart courtesy of www.stockcharts.com

Supply Chains at Risk as China Tightens COVID Restrictions Further

Shanghai is tightening its COVID-19 restrictions again after fleetingly starting to relax them, frustrating residents who had hoped more than a month-long lockdown was easing along with new cases in the city’s financial center. However, Tuesday, May 10, marked the suspension of service on the last two subway lines in the city that had been operating. The shutdown idled the city’s entire subway system.

The lockdowns in China have affected at least 373 million people, including roughly 40% of the country’s gross domestic product (GDP). A key effect is continued disruption of the world’s supply chain for products, such as rice and oil.

Most of Shanghai’s 25 million residents remain in lockdown, with Chinese military and additional health workers assisting in the response. Shanghai, home to the world’s largest port, has strained to unload cargo due to strict regulations that have caused shipping containers to stack up

Some frustrated Shanghai residents have taken videos that went viral to show residents complaining from high-rise buildings about needing food. But government officials are trying to crack down on the posting of such expressions of frustration.

Also in China, young children with COVID-19 have been separated forcibly from their parents, sparking public discord, as Chinese leaders seek to stop the spread of a new, contagious subvariant of Omicron, BA.2. The variant also is causing new infections in European nations such as Germany, the Netherlands and Switzerland.

U.S. COVID Deaths Near 1 Million Milestone

U.S. COVID-19 cases, as of May 11, hit 82,059,839, with deaths rising to 998,048. America still has the dubious distinction as the nation with the most COVID-19 cases and deaths.

COVID-19 deaths worldwide exceeded 6.25 million to total 6,255,457 on May 11, according to Johns Hopkins University. Cases across the globe have jumped to 518,736,189.

As of May 10, 258,229,583 people, or 77.8% of the U.S. population, have obtained at least one dose of a COVID-19 vaccine, the CDC reported. Fully vaccinated people total 220,223,617 or 66.3% of the U.S. population, according to the CDC. America also has topped a key milestone by giving a COVID-19 booster vaccine to 101.4 million people.

The eight farming investments to buy give investors a chance to profit from rising food prices. Investors may find some recent price drops in farming stocks and funds offer a reduced buy price that may not last long if Consumer Price Index and Producer Price Index inflation numbers scheduled for release this week show signs of easing.

Paul Dykewicz, www.pauldykewicz.com, is an accomplished, award-winning journalist who has written for Dow Jones, the Wall Street Journal, Investor’s Business Daily, USA Today, the Journal of Commerce, Seeking Alpha, Guru Focus and other publications and websites. Paul, who can be followed on Twitter @PaulDykewicz, is the editor of StockInvestor.com and DividendInvestor.com, a writer for both websites and a columnist. He further is editorial director of Eagle Financial Publications in Washington, D.C., where he edits monthly investment newsletters, time-sensitive trading alerts, free e-letters and other investment reports. Paul previously served as business editor of Baltimore’s Daily Record newspaper. Paul also is the author of an inspirational book, “Holy Smokes! Golden Guidance from Notre Dame’s Championship Chaplain,” with a foreword by former national championship-winning football coach Lou Holtz. The book is great as a gift and is endorsed by Joe Montana, Joe Theismann, Ara Parseghian, “Rocket” Ismail, Reggie Brooks, Dick Vitale and many others. Call 202-677-4457 for multiple-book pricing.

The post Eight Farming Investments to Buy as Putin Ruins Ukrainian Exports appeared first on Stock Investor.

Read More

Continue Reading

Government

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A…

Published

on

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A U.S. Centers for Disease Control (CDC) paper released Thursday found that thousands of young children have been taken to the emergency room over the past several years after taking the very common sleep-aid supplement melatonin.

The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia, on April 23, 2020. (Tami Chappell/AFP via Getty Images)

The agency said that melatonin, which can come in gummies that are meant for adults, was implicated in about 7 percent of all emergency room visits for young children and infants “for unsupervised medication ingestions,” adding that many incidents were linked to the ingestion of gummy formulations that were flavored. Those incidents occurred between the years 2019 and 2022.

Melatonin is a hormone produced by the human body to regulate its sleep cycle. Supplements, which are sold in a number of different formulas, are generally taken before falling asleep and are popular among people suffering from insomnia, jet lag, chronic pain, or other problems.

The supplement isn’t regulated by the U.S. Food and Drug Administration and does not require child-resistant packaging. However, a number of supplement companies include caps or lids that are difficult for children to open.

The CDC report said that a significant number of melatonin-ingestion cases among young children were due to the children opening bottles that had not been properly closed or were within their reach. Thursday’s report, the agency said, “highlights the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight,” including melatonin.

The approximately 11,000 emergency department visits for unsupervised melatonin ingestions by infants and young children during 2019–2022 highlight the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight.

The CDC notes that melatonin use among Americans has increased five-fold over the past 25 years or so. That has coincided with a 530 percent increase in poison center calls for melatonin exposures to children between 2012 and 2021, it said, as well as a 420 percent increase in emergency visits for unsupervised melatonin ingestion by young children or infants between 2009 and 2020.

Some health officials advise that children under the age of 3 should avoid taking melatonin unless a doctor says otherwise. Side effects include drowsiness, headaches, agitation, dizziness, and bed wetting.

Other symptoms of too much melatonin include nausea, diarrhea, joint pain, anxiety, and irritability. The supplement can also impact blood pressure.

However, there is no established threshold for a melatonin overdose, officials have said. Most adult melatonin supplements contain a maximum of 10 milligrams of melatonin per serving, and some contain less.

Many people can tolerate even relatively large doses of melatonin without significant harm, officials say. But there is no antidote for an overdose. In cases of a child accidentally ingesting melatonin, doctors often ask a reliable adult to monitor them at home.

Dr. Cora Collette Breuner, with the Seattle Children’s Hospital at the University of Washington, told CNN that parents should speak with a doctor before giving their children the supplement.

“I also tell families, this is not something your child should take forever. Nobody knows what the long-term effects of taking this is on your child’s growth and development,” she told the outlet. “Taking away blue-light-emitting smartphones, tablets, laptops, and television at least two hours before bed will keep melatonin production humming along, as will reading or listening to bedtime stories in a softly lit room, taking a warm bath, or doing light stretches.”

In 2022, researchers found that in 2021, U.S. poison control centers received more than 52,000 calls about children consuming worrisome amounts of the dietary supplement. That’s a six-fold increase from about a decade earlier. Most such calls are about young children who accidentally got into bottles of melatonin, some of which come in the form of gummies for kids, the report said.

Dr. Karima Lelak, an emergency physician at Children’s Hospital of Michigan and the lead author of the study published in 2022 by the CDC, found that in about 83 percent of those calls, the children did not show any symptoms.

However, other children had vomiting, altered breathing, or other symptoms. Over the 10 years studied, more than 4,000 children were hospitalized, five were put on machines to help them breathe, and two children under the age of two died. Most of the hospitalized children were teenagers, and many of those ingestions were thought to be suicide attempts.

Those researchers also suggested that COVID-19 lockdowns and virtual learning forced more children to be at home all day, meaning there were more opportunities for kids to access melatonin. Also, those restrictions may have caused sleep-disrupting stress and anxiety, leading more families to consider melatonin, they suggested.

The Associated Press contributed to this report.

Tyler Durden Mon, 03/11/2024 - 21:40

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Spread & Containment

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Trending